Ultivue

High definition tissue multiplexing

[Ultivue @Ultivue]

Whether you’re cozy next to the fire🔥, unwinding with a tropical getaway 🌴, or focused on finishing that year end project 👩‍🔬, we hope you find some time to rest, relax and enjoy the holidays.

We look forward to profiling cancer biology with you in 2023! 🎆

[Ultivue @Ultivue]

We are thrilled to announce true automated (Leica Biosystems) multiplexed co-detection of protein and RNA biomarkers on a single FFPE tissue section powered by InSituPlex® technology. https://t.co/kmhrfxXT63 #multiplexed, #multiomics, #automated, #precisionmedicine

[Ultivue @Ultivue]

Which image analysis tools are optimal for mIF assays? What are best practices in digital pathology when it comes to AI driven analysis?
Our own Angela Vasaturo and Lorcan Sherry from OracleBio answered questions on viewers’ minds.
https://t.co/Vrn1yCguwF

[Ultivue @Ultivue]

There's still time left to register for this exciting unique event tomorrow, November 15th at 9am EST hosted by The Pathologist and featuring experts from Ionpath, Nucleai and Canopy Biosciences. https://t.co/zfafeJjv3y

[Ultivue @Ultivue]

Attending Society for Immunotherapy of Cancer (SITC) 2022 this year, then come and check out our poster #60 this Friday, Nov. 11th.

[Ultivue @Ultivue]

Ultivue is pleased to announce a collaborative agreement with Evident Scientific to promote whole slide imaging using multiplexed immunofluorescence (mIF) assays to advance translational research in the Americas.
https://t.co/xQR23pEIAH

[Ultivue @Ultivue]

Have you been wondering about designing assays, controls, tissue processing and more? Our own Angela Vasaturo and Lorcan Sherry from OracleBio answered some of the questions on viewers’ minds about mIF assays and AI-driven image analysis.
https://t.co/OeOfgfwDBy

[Ultivue @Ultivue]

Don't forget to join us for this exciting unique event November 15th at 9am EST hosted by The Pathologist and featuring experts from Ionpath, Nucleai and Canopy Biosciences to address the importance of spatial information in tissue biology. https://t.co/KCXX1RiOqn

[Ultivue @Ultivue]

Have you already heard about ImmunoStart? This is a great way to find out for yourself what Ultivue can do for you.
You get:
👩‍🔬Any FixVUE panel, up to 20 slides
📸mIF and H&E, scanning and stacking
🖥️Complete image analysis

Talk to us: https://t.co/vicZeZW09Z

[Ultivue @Ultivue]

Why Spatial Biology? Join us for this exciting unique event November 15th at 9am EST hosted by The Pathologist and featuring additional speakers from Ionpath, Nucleai and Canopy Biosciences where we dive into some case studies looking at spatial biology. https://t.co/OBqfQ9WVvc

[Ultivue @Ultivue]

The ImmunoPro8 FixVUE panel gives you a comprehensive look at the tumor microenvironment with a set of 8 markers that effectively profile the cellular landscape.
Included markers: CD3, CD8, CD68, Ki67, FoxP3, PD-1, PD-L1, CK/Sox10
Find out more: https://t.co/YEUwBFQuYP

[Ultivue @Ultivue]

TODAY!!! You still have time left to learn more about spatially defining your immune cell types in cancer. Register for our latest webinar next Wednesday, Oct. 26th at 11am EST and let us help you design your next experiment. https://t.co/WjkmlchEvp

[Ultivue @Ultivue]

📢 Have you seen what our mIF services can do for you? Announcing ImmunoStart – get started with your first service project at Ultivue!

Now’s the perfect time to see the difference. Contact us to find out more ➡️ https://t.co/3a0KQq69p6

[Ultivue @Ultivue]

You still have time left to learn more about spatially defining your immune cell types in cancer. Register for our latest webinar next Wednesday, Oct. 26th at 11am EST and let us help you design your next experiment. https://t.co/TUVs97Bgbk

[Ultivue @Ultivue]

Ultivue is pleased to announce that it has entered into an agreement with ZEISS to co-market multiplex biomarker assays for tissue phenotyping with the ZEISS Axioscan whole slide imaging system for data acquisition and analysis.
https://t.co/tJUZwORtjX

[Ultivue @Ultivue]

New data and a great publication out of University of Brussels conducting a phase 1 trial in patients with advanced melanoma. The group utilized our IO8 FixVUE panel to monitor treatment responses and biology of the TME. Check out the paper here, https://t.co/VWlS6PFIRG

[Ultivue @Ultivue]

Its been a busy morning so far at Oxford Global Conferences, Biomarkers US in San Diego. Stop by and come and chat with our scientific team and let us help you plan your multiplexed experiments for all your spatial needs. https://t.co/0xiT2ml7oh

[Ultivue @Ultivue]

Attending the Oxford Global Conferences, Biomarkers US Oct.3rd and 4th in San Diego? Stop by and come and chat with our scientific team and let us help you plan your multiplexed experiments for all your spatial needs. https://t.co/y4IqTTbrt6

[Ultivue @Ultivue]

Attending the International Spatial Biology Congress in The Hague? Stop by our booth and come chat with us for all your multiplexing and spatial needs. https://t.co/h7UcrsNKxI

[Ultivue @Ultivue]

Please join us at our talk on "The Importance of Lymphocyte Distribution from Clinical Biopsies: Spatial Attributes that Make a Difference", at the Hanson Wade 12th World Clinical Biomarkers & CDx Summit in Boston. https://t.co/eaKvXS8mKk